Click for best price
Pancreatic Cancer Drugs Market Size, Share 2022
Pancreatic cancer is caused by the unrestrained growth of cells in the pancreas. This abnormal, uncontrolled growth of cells leads to the formation of lumps of tissue, commonly referred to as tumors. The presence of tumors hinders the normal functioning of pancreas.
This report contains market size and forecasts of Pancreatic Cancer Drugs in Global, including the following market information:
Global Pancreatic Cancer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pancreatic Cancer Drugs market was valued at 2545.8 million in 2021 and is projected to reach US$ 3751.3 million by 2028, at a CAGR of 5.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Abraxane Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pancreatic Cancer Drugs include Eli Lilly and Company, Celgene, Roche, Novartis, Clovis Oncology, Amgen, Merck, Teva Pharmaceutical Industries and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pancreatic Cancer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pancreatic Cancer Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pancreatic Cancer Drugs Market Segment Percentages, by Type, 2021 (%)
Abraxane
Gemzar
5-FU
Others
Global Pancreatic Cancer Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pancreatic Cancer Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Pancreatic Cancer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pancreatic Cancer Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pancreatic Cancer Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pancreatic Cancer Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Celgene
Roche
Novartis
Clovis Oncology
Amgen
Merck
Teva Pharmaceutical Industries
Pfizer
PharmaCyte Biotech
| Report Attributes |
Report Details |
| Report Title |
Pancreatic Cancer Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pancreatic Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pancreatic Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pancreatic Cancer Drugs Overall Market Size
2.1 Global Pancreatic Cancer Drugs Market Size: 2021 VS 2028
2.2 Global Pancreatic Cancer Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pancreatic Cancer Drugs Players in Global Market
3.2 Top Global Pancreatic Cancer Drugs Companies Ranked by Revenue
3.3 Global Pancreatic Cancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pancreatic Cancer Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pancreatic Cancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pancreatic Cancer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pancreatic Cancer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pancreatic Cancer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pancreatic Cancer Drugs Market Size Markets, 2021 & 2028
4.1.2 Abraxane
4.1.3 Gemzar
4.1.4 5-FU
4.1.5 Others
4.2 By Type - Global Pancreatic Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Pancreatic Cancer Drugs Revenue, 2017-2022
4.2.2 By Type - Global Pancreatic Cancer Drugs Revenue, 2023-2028
4.2.3 By Type - Global Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pancreatic Cancer Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Pancreatic Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Pancreatic Cancer Drugs Revenue, 2017-2022
5.2.2 By Application - Global Pancreatic Cancer Drugs Revenue, 2023-2028
5.2.3 By Application - Global Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pancreatic Cancer Drugs Market Size, 2021 & 2028
6.2 By Region - Global Pancreatic Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Pancreatic Cancer Drugs Revenue, 2017-2022
6.2.2 By Region - Global Pancreatic Cancer Drugs Revenue, 2023-2028
6.2.3 By Region - Global Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pancreatic Cancer Drugs Revenue, 2017-2028
6.3.2 US Pancreatic Cancer Drugs Market Size, 2017-2028
6.3.3 Canada Pancreatic Cancer Drugs Market Size, 2017-2028
6.3.4 Mexico Pancreatic Cancer Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pancreatic Cancer Drugs Revenue, 2017-2028
6.4.2 Germany Pancreatic Cancer Drugs Market Size, 2017-2028
6.4.3 France Pancreatic Cancer Drugs Market Size, 2017-2028
6.4.4 U.K. Pancreatic Cancer Drugs Market Size, 2017-2028
6.4.5 Italy Pancreatic Cancer Drugs Market Size, 2017-2028
6.4.6 Russia Pancreatic Cancer Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Pancreatic Cancer Drugs Market Size, 2017-2028
6.4.8 Benelux Pancreatic Cancer Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pancreatic Cancer Drugs Revenue, 2017-2028
6.5.2 China Pancreatic Cancer Drugs Market Size, 2017-2028
6.5.3 Japan Pancreatic Cancer Drugs Market Size, 2017-2028
6.5.4 South Korea Pancreatic Cancer Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Pancreatic Cancer Drugs Market Size, 2017-2028
6.5.6 India Pancreatic Cancer Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pancreatic Cancer Drugs Revenue, 2017-2028
6.6.2 Brazil Pancreatic Cancer Drugs Market Size, 2017-2028
6.6.3 Argentina Pancreatic Cancer Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pancreatic Cancer Drugs Revenue, 2017-2028
6.7.2 Turkey Pancreatic Cancer Drugs Market Size, 2017-2028
6.7.3 Israel Pancreatic Cancer Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Pancreatic Cancer Drugs Market Size, 2017-2028
6.7.5 UAE Pancreatic Cancer Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Pancreatic Cancer Drugs Major Product Offerings
7.1.4 Eli Lilly and Company Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly and Company Key News
7.2 Celgene
7.2.1 Celgene Corporate Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Pancreatic Cancer Drugs Major Product Offerings
7.2.4 Celgene Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.2.5 Celgene Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pancreatic Cancer Drugs Major Product Offerings
7.3.4 Roche Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Pancreatic Cancer Drugs Major Product Offerings
7.4.4 Novartis Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Clovis Oncology
7.5.1 Clovis Oncology Corporate Summary
7.5.2 Clovis Oncology Business Overview
7.5.3 Clovis Oncology Pancreatic Cancer Drugs Major Product Offerings
7.5.4 Clovis Oncology Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.5.5 Clovis Oncology Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Pancreatic Cancer Drugs Major Product Offerings
7.6.4 Amgen Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Pancreatic Cancer Drugs Major Product Offerings
7.7.4 Merck Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.7.5 Merck Key News
7.8 Teva Pharmaceutical Industries
7.8.1 Teva Pharmaceutical Industries Corporate Summary
7.8.2 Teva Pharmaceutical Industries Business Overview
7.8.3 Teva Pharmaceutical Industries Pancreatic Cancer Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.8.5 Teva Pharmaceutical Industries Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Pancreatic Cancer Drugs Major Product Offerings
7.9.4 Pfizer Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 PharmaCyte Biotech
7.10.1 PharmaCyte Biotech Corporate Summary
7.10.2 PharmaCyte Biotech Business Overview
7.10.3 PharmaCyte Biotech Pancreatic Cancer Drugs Major Product Offerings
7.10.4 PharmaCyte Biotech Pancreatic Cancer Drugs Revenue in Global Market (2017-2022)
7.10.5 PharmaCyte Biotech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pancreatic Cancer Drugs Market Opportunities & Trends in Global Market
Table 2. Pancreatic Cancer Drugs Market Drivers in Global Market
Table 3. Pancreatic Cancer Drugs Market Restraints in Global Market
Table 4. Key Players of Pancreatic Cancer Drugs in Global Market
Table 5. Top Pancreatic Cancer Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pancreatic Cancer Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pancreatic Cancer Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pancreatic Cancer Drugs Product Type
Table 9. List of Global Tier 1 Pancreatic Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pancreatic Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pancreatic Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pancreatic Cancer Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pancreatic Cancer Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pancreatic Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pancreatic Cancer Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pancreatic Cancer Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pancreatic Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pancreatic Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pancreatic Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pancreatic Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pancreatic Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pancreatic Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pancreatic Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pancreatic Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly and Company Corporate Summary
Table 31. Eli Lilly and Company Pancreatic Cancer Drugs Product Offerings
Table 32. Eli Lilly and Company Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Pancreatic Cancer Drugs Product Offerings
Table 35. Celgene Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Pancreatic Cancer Drugs Product Offerings
Table 38. Roche Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Pancreatic Cancer Drugs Product Offerings
Table 41. Novartis Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Clovis Oncology Corporate Summary
Table 43. Clovis Oncology Pancreatic Cancer Drugs Product Offerings
Table 44. Clovis Oncology Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Pancreatic Cancer Drugs Product Offerings
Table 47. Amgen Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Pancreatic Cancer Drugs Product Offerings
Table 50. Merck Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical Industries Corporate Summary
Table 52. Teva Pharmaceutical Industries Pancreatic Cancer Drugs Product Offerings
Table 53. Teva Pharmaceutical Industries Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Pancreatic Cancer Drugs Product Offerings
Table 56. Pfizer Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 57. PharmaCyte Biotech Corporate Summary
Table 58. PharmaCyte Biotech Pancreatic Cancer Drugs Product Offerings
Table 59. PharmaCyte Biotech Pancreatic Cancer Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pancreatic Cancer Drugs Segment by Type in 2021
Figure 2. Pancreatic Cancer Drugs Segment by Application in 2021
Figure 3. Global Pancreatic Cancer Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pancreatic Cancer Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pancreatic Cancer Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pancreatic Cancer Drugs Revenue in 2021
Figure 8. By Type - Global Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 12. US Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 24. China Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pancreatic Cancer Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pancreatic Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly and Company Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Clovis Oncology Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical Industries Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. PharmaCyte Biotech Pancreatic Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
